Home / MDRX : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does MDRX make money? Does MDRX have pricing power? What's the Earnings Whisper? Will MDRX profit more as the business scales? What is MDRX's management track record? Is MDRX's current price justified?

Veradigm Inc.

$4.6 +$0.05 (+1.10%)

OTC · 11 Sep 2026 16:40 UTC

Previous Close

$4.55

Day Range

$4.55$4.65

Year Range

$3$6

Market Cap

781.22M

AVG Volume

47.84K

Trailing/Forward PE

-6.87/10.7

PEG ratio

-0.16

Dividend Yield

Next Earnings Date

2026-11-06

Primary Exchange

Other OTC

Revenue (USD)

MDRX Revenue (USD) by quarter
Period	Revenue (USD)
22 Q3	151.92M
22 Q2	150.9M
22 Q1	142.67M
21 Q4	391.7M
21 Q3	369.27M
21 Q2	373.71M
21 Q1	368.35M
20 Q4	277.73M
20 Q3	402.03M
20 Q2	406.22M

Net Income (USD)

MDRX Net Income (USD) by quarter
Period	Net Income (USD)
22 Q3	9.35M
22 Q2	-64.03M
22 Q1	22.86M
21 Q4	87.28M
21 Q3	16.18M
21 Q2	21.93M
21 Q1	9.06M
20 Q4	727.82M
20 Q3	2.4M
20 Q2	-7.61M

Operating Income (USD)

MDRX Operating Income (USD) by quarter
Period	Operating Income (USD)
22 Q3	25M
22 Q2	-5.36M
22 Q1	6.57M
21 Q4	41.38M
21 Q3	18.48M
21 Q2	16.82M
21 Q1	7.73M
20 Q4	-142.99M
20 Q3	-11.16M
20 Q2	-24.66M

EBITDA (USD)

MDRX EBITDA (USD) by quarter
Period	EBITDA (USD)
22 Q3	39.85M
22 Q2	10.93M
22 Q1	20.35M
21 Q4	155.74M
21 Q3	47.19M
21 Q2	49.94M
21 Q1	24.8M
20 Q4	-83.37M
20 Q3	35.31M
20 Q2	35.08M

Cash Flows (USD)

MDRX Cash Flows (USD) by quarter
Period	Cash Flows (USD)
22 Q4	19.61M
22 Q3	20M
22 Q2	-11.6M
22 Q1	59.32M
21 Q4	46.6M
21 Q3	45.2M
21 Q2	-209.52M
21 Q1	-3.8M
20 Q4	-197.71M
20 Q3	29.52M

EPS (USD)

MDRX EPS (USD) by quarter
Period	EPS (USD)
22 Q3	0.12
22 Q2	0.03
22 Q1	0.17
21 Q4	0.68
21 Q3	0.12
21 Q2	0.15
21 Q1	0.06
20 Q4	4.57
20 Q3	0
20 Q2	-0.05

Expenses (USD)

MDRX Expenses (USD) by quarter
Period	Expenses (USD)
22 Q4	186K
22 Q3	64.37M
22 Q2	92.56M
22 Q1	74.68M
21 Q4	140.52M
21 Q3	59.12M
21 Q2	138.9M
21 Q1	139.25M
20 Q4	147.04M
20 Q3	167.03M
20 Q2	160.66M

Cash & Debt (USD)

MDRX Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
22 Q3	492.6M
22 Q2	500.16M
22 Q1	82.78M
21 Q4	188.35M
21 Q3	214.18M
21 Q2	229.25M
21 Q1	513.4M
20 Q4	531.1M
20 Q3	218.7M
20 Q2	199M

Debt ratios

MDRX Debt ratios by quarter
Period	Debt ratios
22 Q3	-1.21
22 Q2	-1.2
22 Q1	1.15
21 Q4	0.89
21 Q3	6.36
21 Q2	10.62
21 Q1	-19.77
20 Q4	-15.75
20 Q3	7.63
20 Q2	6.25

Margins

MDRX Margins by quarter
Period	Margins
22 Q3	54.92%
22 Q2	52.67%
22 Q1	51.5%
21 Q4	43.15%
21 Q3	79.58%
21 Q2	37.66%
21 Q1	37.49%
20 Q4	29.76%
20 Q3	42.67%
20 Q2	42.96%

Return on Capital

MDRX Return on Capital by quarter
Period	Return on Capital
22 Q3	0.79%
22 Q2	-5.35%
22 Q1	1.69%
21 Q4	6.2%
21 Q3	1.14%
21 Q2	1.57%
21 Q1	0.54%
20 Q4	43.68%
20 Q3	0.2%
20 Q2	-0.61%

Shares Outstanding

MDRX Shares Outstanding by quarter
Period	Shares Outstanding
22 Q3	128.9M
22 Q2	114.3M
22 Q1	138.7M
21 Q4	120.1M
21 Q3	123.9M
21 Q2	136.65M
21 Q1	140.19M
20 Q4	150.85M
20 Q3	161.1M
20 Q2	162.68M

Dividends (USD)

MDRX Dividends (USD) by quarter
Period	Dividends (USD)
Oct 08	5.23

Employee Count

MDRX Employee Count by quarter
Period	Employee Count
2024	2.3K
2022	1.04K
2021	8K
2020	8.4K
2019	9.6K
2018	9.5K
2017	8.9K
2016	7.5K
2015	6.9K
2014	7.2K

Book Value Per Share (USD)

MDRX Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
22 Q3	9.13
22 Q2	10.47
22 Q1	9.76
21 Q4	11.72
21 Q3	11.45
21 Q2	10.2
21 Q1	11.97
20 Q4	11.05
20 Q3	7.5
20 Q2	7.64

Total Assets (USD)

MDRX Total Assets (USD) by quarter
Period	Total Assets (USD)
22 Q3	1.69B
22 Q2	1.71B
22 Q1	2.43B
21 Q4	2.43B
21 Q3	2.48B
21 Q2	2.54B
21 Q1	2.87B
20 Q4	2.92B
20 Q3	3.15B
20 Q2	3.19B

PE Ratio

MDRX PE Ratio by quarter
Period	PE Ratio
Mar 23	30.56
Mar 23	30.49
Mar 23	32.26
Mar 23	35.1
Feb 23	39.16
Feb 23	41.14
Feb 23	40.58
Feb 23	40.21
Jan 23	41.25
Jan 23	43
Jan 23	44.67
Jan 23	40.91
Dec 22	41
Dec 22	41.51
Dec 22	41.32
Dec 22	43.09
Dec 22	44.3
Nov 22	43.11
Nov 22	42.11
Nov 22	42
Nov 22	28.76
Oct 22	27.09
Oct 22	26.15
Oct 22	25.89
Oct 22	26.43
Sep 22	27.95
Sep 22	30.59
Sep 22	29.89
Sep 22	31.2
Sep 22	30.52
Aug 22	31.31
Aug 22	31.51
Aug 22	32.11
Aug 22	16.4
Jul 22	14.8
Jul 22	14.03
Jul 22	13.72
Jul 22	13.73
Jul 22	14.18
Jun 22	14.5
Jun 22	14.03
Jun 22	15.63
Jun 22	16.25
May 22	15.81
May 22	15.65
May 22	16.88
May 22	16.65
Apr 22	18.46
Apr 22	19.34
Apr 22	19.94
Apr 22	20.33
Apr 22	20.63
Mar 22	19.44
Mar 22	19.29
Mar 22	18.74
Mar 22	19.12
Feb 22	17.4
Feb 22	3.26
Feb 22	3.44
Feb 22	3.3
Jan 22	3.29
Jan 22	2.74
Jan 22	2.86
Jan 22	2.82
Dec 21	2.95
Dec 21	2.91
Dec 21	2.96
Dec 21	2.83
Dec 21	2.67
Nov 21	2.65
Nov 21	2.74
Nov 21	2.62
Nov 21	2.41
Oct 21	2.47
Oct 21	2.48
Oct 21	2.56
Oct 21	2.51
Oct 21	2.44
Sep 21	2.46
Sep 21	2.56
Sep 21	2.57
Sep 21	2.73
Aug 21	2.83
Aug 21	2.85
Aug 21	3.05
Aug 21	3.12
Jul 21	3.27
Jul 21	3.31
Jul 21	3.35
Jul 21	3.48
Jul 21	3.52
Jun 21	3.6
Jun 21	3.35
Jun 21	3.46
Jun 21	3.46
May 21	3.33
May 21	3.29
May 21	3.25
May 21	3.11
Apr 21	2.98

Free Cash Flow Yield

MDRX Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Mar 23	6.74%
Mar 23	6.76%
Mar 23	6.39%
Mar 23	5.87%
Feb 23	5.26%
Feb 23	5.01%
Feb 23	5.08%
Feb 23	5.13%
Jan 23	5%
Jan 23	4.79%
Jan 23	4.61%
Jan 23	5.04%
Dec 22	5.03%
Dec 22	4.97%
Dec 22	4.99%
Dec 22	4.78%
Dec 22	4.65%
Nov 22	4.78%
Nov 22	4.89%
Nov 22	4.91%
Nov 22	7.79%
Oct 22	8.27%
Oct 22	8.57%
Oct 22	8.65%
Oct 22	8.48%
Sep 22	8.01%
Sep 22	7.32%
Sep 22	7.49%
Sep 22	7.18%
Sep 22	7.34%
Aug 22	7.16%
Aug 22	7.11%
Aug 22	6.98%
Aug 22	-2.4%
Jul 22	-2.66%
Jul 22	-2.81%
Jul 22	-2.87%
Jul 22	-2.87%
Jul 22	-2.78%
Jun 22	-2.72%
Jun 22	-2.81%
Jun 22	-2.52%
Jun 22	-2.42%
May 22	-2.49%
May 22	-2.52%
May 22	-2.33%
May 22	-5.43%
Apr 22	-4.9%
Apr 22	-4.67%
Apr 22	-4.53%
Apr 22	-4.45%
Apr 22	-4.38%
Mar 22	-4.65%
Mar 22	-4.69%
Mar 22	-4.82%
Mar 22	-4.73%
Feb 22	-5.19%
Feb 22	-14.48%
Feb 22	-13.71%
Feb 22	-14.31%
Jan 22	-14.37%
Jan 22	-17.23%
Jan 22	-16.51%
Jan 22	-16.73%
Dec 21	-16%
Dec 21	-16.22%
Dec 21	-15.93%
Dec 21	-16.7%
Dec 21	-17.65%
Nov 21	-17.8%
Nov 21	-17.26%
Nov 21	-18.01%
Nov 21	-19.55%
Oct 21	-20.26%
Oct 21	-20.23%
Oct 21	-19.59%
Oct 21	-19.99%
Oct 21	-20.54%
Sep 21	-20.38%
Sep 21	-19.58%
Sep 21	-19.51%
Sep 21	-18.37%
Aug 21	-17.68%
Aug 21	-17.57%
Aug 21	-16.41%
Aug 21	-16.05%
Jul 21	-7.34%
Jul 21	-7.26%
Jul 21	-7.16%
Jul 21	-6.9%
Jul 21	-6.82%
Jun 21	-6.68%
Jun 21	-7.16%
Jun 21	-6.93%
Jun 21	-6.93%
May 21	-7.21%
May 21	-7.3%
May 21	-7.4%
May 21	-7.72%
Apr 21	-8.06%

Price to Sales

MDRX Price to Sales by quarter
Period	Price to Sales
Mar 23	2.02
Mar 23	2.02
Mar 23	2.14
Mar 23	2.32
Feb 23	2.59
Feb 23	2.73
Feb 23	2.69
Feb 23	2.66
Jan 23	2.73
Jan 23	2.85
Jan 23	2.96
Jan 23	2.71
Dec 22	2.72
Dec 22	2.75
Dec 22	2.74
Dec 22	2.85
Dec 22	2.93
Nov 22	2.86
Nov 22	2.79
Nov 22	2.78
Nov 22	1.7
Oct 22	1.6
Oct 22	1.54
Oct 22	1.53
Oct 22	1.56
Sep 22	1.65
Sep 22	1.81
Sep 22	1.77
Sep 22	1.84
Sep 22	1.8
Aug 22	1.85
Aug 22	1.86
Aug 22	1.9
Aug 22	1.9
Jul 22	1.72
Jul 22	1.63
Jul 22	1.59
Jul 22	1.59
Jul 22	1.65
Jun 22	1.68
Jun 22	1.63
Jun 22	1.81
Jun 22	1.89
May 22	1.84
May 22	1.82
May 22	1.96
May 22	1.49
Apr 22	1.65
Apr 22	1.73
Apr 22	1.78
Apr 22	1.82
Apr 22	1.85
Mar 22	1.74
Mar 22	1.73
Mar 22	1.68
Mar 22	1.71
Feb 22	1.56
Feb 22	1.82
Feb 22	1.92
Feb 22	1.84
Jan 22	1.83
Jan 22	1.53
Jan 22	1.59
Jan 22	1.57
Dec 21	1.65
Dec 21	1.62
Dec 21	1.65
Dec 21	1.58
Dec 21	1.49
Nov 21	1.48
Nov 21	1.53
Nov 21	1.46
Nov 21	1.35
Oct 21	1.32
Oct 21	1.33
Oct 21	1.37
Oct 21	1.34
Oct 21	1.31
Sep 21	1.32
Sep 21	1.37
Sep 21	1.38
Sep 21	1.46
Aug 21	1.52
Aug 21	1.53
Aug 21	1.63
Aug 21	1.67
Jul 21	1.65
Jul 21	1.67
Jul 21	1.69
Jul 21	1.75
Jul 21	1.77
Jun 21	1.81
Jun 21	1.69
Jun 21	1.74
Jun 21	1.74
May 21	1.68
May 21	1.66
May 21	1.63
May 21	1.56
Apr 21	1.5

EV/EBITDA

MDRX EV/EBITDA by quarter
Period	EV/EBITDA
Mar 23	6.26
Mar 23	6.25
Mar 23	6.68
Mar 23	7.37
Feb 23	8.37
Feb 23	8.85
Feb 23	8.71
Feb 23	8.62
Jan 23	8.88
Jan 23	9.3
Jan 23	9.71
Jan 23	8.79
Dec 22	8.82
Dec 22	8.94
Dec 22	8.9
Dec 22	9.33
Dec 22	9.62
Nov 22	9.33
Nov 22	9.09
Nov 22	9.06
Nov 22	6.45
Oct 22	6.01
Oct 22	5.76
Oct 22	5.69
Oct 22	5.83
Sep 22	6.24
Sep 22	6.94
Sep 22	6.75
Sep 22	7.1
Sep 22	6.92
Aug 22	7.13
Aug 22	7.18
Aug 22	7.34
Aug 22	10.05
Jul 22	9.19
Jul 22	8.76
Jul 22	8.6
Jul 22	8.6
Jul 22	8.85
Jun 22	9.02
Jun 22	8.77
Jun 22	9.64
Jun 22	9.97
May 22	9.73
May 22	9.65
May 22	10.31
May 22	8.95
Apr 22	9.82
Apr 22	10.25
Apr 22	10.54
Apr 22	10.73
Apr 22	10.87
Mar 22	10.3
Mar 22	10.22
Mar 22	9.96
Mar 22	10.14
Feb 22	9.31
Feb 22	71.87
Feb 22	75.53
Feb 22	72.64
Jan 22	72.38
Jan 22	61.43
Jan 22	63.81
Jan 22	63.07
Dec 21	65.64
Dec 21	64.83
Dec 21	65.93
Dec 21	63.16
Dec 21	60.11
Nov 21	59.66
Nov 21	61.33
Nov 21	59.02
Nov 21	54.87
Oct 21	81.18
Oct 21	81.28
Oct 21	83.58
Oct 21	82.15
Oct 21	80.2
Sep 21	80.77
Sep 21	83.64
Sep 21	83.89
Sep 21	88.45
Aug 21	91.47
Aug 21	91.98
Aug 21	97.72
Aug 21	99.66
Jul 21	182.76
Jul 21	185.13
Jul 21	187.86
Jul 21	195.8
Jul 21	198.18
Jun 21	202.92
Jun 21	187.74
Jun 21	194.62
Jun 21	194.62
May 21	186.44
May 21	183.95
May 21	181.1
May 21	172.68
Apr 21	164.74

Price/Operating Cashflow

MDRX Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Mar 23	10.54
Mar 23	10.52
Mar 23	11.13
Mar 23	12.1
Feb 23	13.51
Feb 23	14.19
Feb 23	14
Feb 23	13.87
Jan 23	14.23
Jan 23	14.83
Jan 23	15.41
Jan 23	14.11
Dec 22	14.14
Dec 22	14.32
Dec 22	14.25
Dec 22	14.86
Dec 22	15.28
Nov 22	14.87
Nov 22	14.52
Nov 22	14.48
Nov 22	9.5
Oct 22	8.95
Oct 22	8.64
Oct 22	8.55
Oct 22	8.73
Sep 22	9.23
Sep 22	10.1
Sep 22	9.87
Sep 22	10.3
Sep 22	10.08
Aug 22	10.34
Aug 22	10.41
Aug 22	10.61
Feb 21	31.64
Feb 21	32.64
Feb 21	32.7
Jan 21	31.53
Jan 21	32.52
Jan 21	31.8
Jan 21	29.14
Dec 20	27.59
Dec 20	27.23
Dec 20	26.75
Dec 20	27.4
Dec 20	27.54
Nov 20	27.15
Nov 20	25.17
Nov 20	23.41
Nov 20	21.46
Oct 20	19.26
Oct 20	26.44
Oct 20	26.8
Oct 20	20.31
Oct 20	20
Sep 20	19.51
Sep 20	19.76
Sep 20	20.98
Sep 20	21.31
Aug 20	21.77
Aug 20	22.18
Aug 20	22.42
Aug 20	22.38
Jul 20	21.79
Jul 20	31.03
Jul 20	31.82
Jul 20	29.13
Jul 20	29.3
Jun 20	27.45
Jun 20	31.42
Jun 20	26.83
Jun 20	30.63
May 20	27.89
May 20	28.33
May 20	25.64
May 20	28.25
May 20	21.69
Apr 20	21.8
Apr 20	22.85
Apr 20	25.44
Apr 20	21.59
Mar 20	23.09
Mar 20	19.31
Mar 20	21.38
Mar 20	26.77
Feb 20	61.86
Feb 20	69.99
Feb 20	72.61
Feb 20	74.5
Jan 20	70.4
Jan 20	73.68
Jan 20	79.59
Jan 20	78.36
Jan 20	79.01
Dec 19	81.14
Dec 19	80.24
Dec 19	78.52
Dec 19	82.54
Nov 19	88.45
Nov 19	89.02
Nov 19	90.17

Price to Book

MDRX Price to Book by quarter
Period	Price to Book
Mar 23	1.44
Mar 23	1.44
Mar 23	1.52
Mar 23	1.65
Feb 23	1.85
Feb 23	1.94
Feb 23	1.91
Feb 23	1.89
Jan 23	1.94
Jan 23	2.03
Jan 23	2.1
Jan 23	1.93
Dec 22	1.93
Dec 22	1.96
Dec 22	1.95
Dec 22	2.03
Dec 22	2.09
Nov 22	2.03
Nov 22	1.98
Nov 22	1.98
Nov 22	1.5
Oct 22	1.41
Oct 22	1.36
Oct 22	1.35
Oct 22	1.38
Sep 22	1.46
Sep 22	1.59
Sep 22	1.56
Sep 22	1.62
Sep 22	1.59
Aug 22	1.63
Aug 22	1.64
Aug 22	1.67
Aug 22	1.8
Jul 22	1.62
Jul 22	1.54
Jul 22	1.5
Jul 22	1.5
Jul 22	1.55
Jun 22	1.59
Jun 22	1.54
Jun 22	1.71
Jun 22	1.78
May 22	1.73
May 22	1.71
May 22	1.85
May 22	1.59
Apr 22	1.76
Apr 22	1.85
Apr 22	1.9
Apr 22	1.94
Apr 22	1.97
Mar 22	1.86
Mar 22	1.84
Mar 22	1.79
Mar 22	1.83
Feb 22	1.66
Feb 22	1.78
Feb 22	1.88
Feb 22	1.8
Jan 22	1.79
Jan 22	1.5
Jan 22	1.56
Jan 22	1.54
Dec 21	1.61
Dec 21	1.59
Dec 21	1.62
Dec 21	1.54
Dec 21	1.46
Nov 21	1.45
Nov 21	1.49
Nov 21	1.43
Nov 21	1.32
Oct 21	1.35
Oct 21	1.35
Oct 21	1.4
Oct 21	1.37
Oct 21	1.33
Sep 21	1.34
Sep 21	1.4
Sep 21	1.4
Sep 21	1.49
Aug 21	1.55
Aug 21	1.56
Aug 21	1.67
Aug 21	1.71
Jul 21	1.43
Jul 21	1.44
Jul 21	1.46
Jul 21	1.52
Jul 21	1.53
Jun 21	1.57
Jun 21	1.46
Jun 21	1.51
Jun 21	1.51
May 21	1.45
May 21	1.43
May 21	1.41
May 21	1.36
Apr 21	1.3

No video analysis for this stock yet. Request one from our team.

News: MDRX

defenseworld.net · 3 Sep 2026

Veradigm (NASDAQ:MDRX) & Augmedix (OTCMKTS:AUGX) Financial Comparison

Insider and Institutional Ownership 87.1% of Augmedix shares are held by institutional investors. 2.3% of Veradigm shares are held by company insiders. Comparatively, 11.0% of Augmedix shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the

businesswire.com · 17 Aug 2026

Veradigm to Participate in Two Upcoming Investor Conferences

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management will be participating in the following investor conferences in September. 2026 Jefferies Healthcare Services and Technology Conference (Nashville, September 15, 2026) Don Trigg, Chief Executive Officer, and Christian Greyenbuhl, Chief Financial Officer, will hold one-on-one meetings and participate in a fireside chat on Tuesda.

AI Analysis

Veradigm Inc.

Video analysis: MDRX

News: MDRX

Veradigm (NASDAQ:MDRX) & Augmedix (OTCMKTS:AUGX) Financial Comparison

Veradigm to Participate in Two Upcoming Investor Conferences

Similar companies